Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Russell 2000 BuyWrite ETF (NY:IWMW)

39.39 +0.03 (+0.08%)
Streaming Delayed Price Updated: 11:21 AM EST, Dec 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about iShares Russell 2000 BuyWrite ETF

< Previous 1 2 3 4 Next >
Mirum Stock Slips On $820M Bluejay Deal — But Wall Street Calls The Hepatitis Drug Seal A 'Steal' ↗
Via Stocktwits
News headline image
Compass Diversified Stock Plunges On ‘Most Significant Loss’ After Fraud Forces Removal Of Three Years Of Financials ↗
The company has removed financial information for the years 2022 to 2024 from its website, citing non-reliance. 
Via Stocktwits
Topics Fraud
American Eagle's Gen Z Playbook Is Working — Sydney Sweeney And Travis Kelce Might Only Be The Opening Act ↗
Via Stocktwits
Archer Aviation Stock Jumps On Tech Deal With Karem For Military Aircraft — Retail Seeks Tangible Progress ↗
Via Stocktwits
News headline image
Capricor Therapeutics Stock Sparks Retail Frenzy As Traders Hail ‘Best Data’ Ahead Of DMD Data Readout ↗
Capricor said in early November that it expects to announce results from the HOPE-3 trial in the coming weeks. 
Via Stocktwits
News headline image
Kohl’s Traders Just Got The CEO They Wanted — And the Stock’s Weekly Breakout Says It All ↗
Last week, KSS stock soared nearly 60%, marking its best weekly performance this year, after Michael Bender was confirmed as full-time CEO. 
Via Stocktwits
Vanda Pharmaceuticals Says FDA Will Take More Time To Decide On Tradipitant Clinical Hold Re-Review ↗
Via Stocktwits
Arrowhead Pharmaceuticals Stock Jumps 22% After Morgan Stanley Hikes Price Target ↗
Via Stocktwits
News headline image
Abercrombie & Fitch Catches Retail Attention After Barclays Raises Price Target On Hollister Momentum ↗
Barclays raised its price target on Abercrombie & Fitch to $94 from $84 and maintained an ‘Equal Weight’ rating, according to TheFly. 
Via Stocktwits
News headline image
AVXL Stock Jumps On Lower Q4 Loss, Anticipation For EMA Approval Of Alzheimer’s Drug ↗
Anavex ended the quarter with cash and cash equivalents of $102.6 million. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Why ANF Stock Is Soaring Before The Bell Today? ↗
Abercrombie now expects net sales to grow in the range of 6% to 7% for fiscal year 2025, compared with the prior forecast of 5% to 7% rise. 
Via Stocktwits
News headline image
KSS Stock Soars Pre-Market After Turnaround Efforts Lift Profit Forecast ↗
Kohl’s now expects annual adjusted earnings per share in the range of $1.25 to $1.45, compared with the previous forecast of $0.50 to $0.80. 
Via Stocktwits
News headline image
Hunterbrook Capital Reveals Short Position In eVTOL Maker Archer Aviation ↗
Hunterbrook said that Archer’s Might electric air taxi never flew at the 2025 Dubai Airshow. 
Via Stocktwits
Topics Lawsuit
Praxis Precision Medicines Stock Drops After Culper Research Reveals Short Position ↗
Via Stocktwits
PACS Group Stock Soars Premarket On Completion Of Audit Committee Probe, Upbeat Full-Year Guidance ↗
Via Stocktwits
Atkore Expands Review Process: CEO To Stay On As It Explores Sale Or Merger Options ↗
Via Stocktwits
News headline image
AGIO Stock Cracks After Sickle-Cell Disease Drug Delivers Mixed Results In Late-Stage Trial ↗
While Mitapivat also showed a reduction in the primary endpoint of annualized rate of sickle cell pain crises (SCPCs) compared to placebo, this trend did not achieve statistical significance, Agios... 
Via Stocktwits
News headline image
Joby Aviation To Launch Electric Air Taxi Test Flights In Saudi Arabia ↗
The company said that under the agreement, Joby will work together with Red Sea Global and The Helicopter Company to establish a "sandbox" for pre-commercial operations. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Archer Aviation Lands Partnership To Deploy Air Taxi In Saudi Arabia ↗
The partnership will focus on the development, testing, and potential integration of Archer’s eVTOL aircraft into RSG’s operations. 
Via Stocktwits
News headline image
Why Did Scholar Rock Soar 26% Today? ↗
The company is planning to reapply for approval of a muscle atrophy therapy in the coming year. 
Via Stocktwits
Topics Earnings
Why Did Outset Medical Stock Tumble Today? ↗
Via Stocktwits
AVXL Stock Draws Retail Attention Ahead Of Company’s Meeting With EMA Committee ↗
Via Stocktwits
MGTX Stock Soared 13% Today – What’s The Eli Lilly Angle? ↗
Via Stocktwits
BHVN Stock Tumbled A Whopping 44% Today – What Did The FDA Letter Say? ↗
Via Stocktwits
News headline image
Topgolf Callaway Brands Jumps 5% After Report Says Talks Are On To Sell Topgolf Unit ↗
According to a report by The Wall Street Journal, citing people familiar with the matter, the deal would value Topgolf at about $1 billion. 
Via Stocktwits
News headline image
Cormedix Stock Soars Pre-Market After Earnings Beat, Higher Full-Year Guidance ↗
The company now expects pro forma net revenue for the full year in a range of $390 million to $410 million, higher than a Wall Street estimate of $283.66 million. 
Via Stocktwits
Topics Earnings
News headline image
Novavax Sees Higher Revenue From Partners For Full-Year, Raises Revenue Guidance ↗
The company recently expanded on its Sanofi partnership to include its Matrix-M adjuvant in Sanofi’s pandemic influenza vaccine candidate program. 
Via Stocktwits
Intuitive Machines To Acquire Lanteris Space Systems In $800 Million Deal ↗
Via Stocktwits
News headline image
Teladoc Stock Shot Up 8% Today: BofA Views It As Differentiated Asset But Remains Cautious On Near-Term Outlook ↗
BofA’s new price target represents a potential upside of about 5% from the stock’s closing price on Thursday. 
Via Stocktwits
News headline image
Tango Therapeutics Stock Soars Pre-Market On $225M Financing, Positive Study Data For Cancer Therapy ↗
CEO Barbara Weber said that across the 16 cancer types enrolled in the trial, the objective response rate (ORR) was 27% in patients with a median follow-up of 9.4 months. 
Via Stocktwits
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.